Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
cases increased » rate increased (Expand Search), levels increased (Expand Search)
c largest » _ largest (Expand Search), c large (Expand Search)
c2 cases » 152 cases (Expand Search), chd cases (Expand Search), 123 cases (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), via large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
Showing 41 - 60 results of 12,807 for search '(((( c largest decrease ) OR ( ((i large) OR (b large)) decrease ))) OR ( c2 cases increased ))*', query time: 0.83s Refine Results
  1. 41
    Expression of NFATc1 is decreased in <i>Tcirg1</i>-knockdown osteoclasts.

    Expression of NFATc1 is decreased in <i>Tcirg1</i>-knockdown osteoclasts. by Dongyan Zhang (640677)

    Published 2020
    Save to List
    Saved in:
  2. 42
    Regional contemporary (1990–1999 mean) precipitation and JULES inundation fraction over the Amazon basin.

    Regional contemporary (1990–1999 mean) precipitation and JULES inundation fraction over the Amazon basin. by Nic Gedney (19762301)

    Published 2024
    Save to List
    Saved in:
  3. 43
    Changes in decadal precipitation and JULES inundation between 1990–1999 and 2089–2098.

    Changes in decadal precipitation and JULES inundation between 1990–1999 and 2089–2098. by Nic Gedney (19762301)

    Published 2024
    Save to List
    Saved in:
  4. 44
    Contemporary mean inundation fraction in the Amazon basin.

    Contemporary mean inundation fraction in the Amazon basin. by Nic Gedney (19762301)

    Published 2024
    Save to List
    Saved in:
  5. 45
    Simulated regional mean wetland seasons.

    Simulated regional mean wetland seasons. by Nic Gedney (19762301)

    Published 2024
    Save to List
    Saved in:
  6. 46
    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx

    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

    Published 2025
    “…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
    Save to List
    Saved in:
  7. 47
    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  8. 48
    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  9. 49
    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  10. 50
    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  11. 51
    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX

    Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
    Save to List
    Saved in:
  12. 52
    <b>Normative values for maximal voluntary isometric contraction of the plantarflexors: A large observational cross-sectional study</b>

    <b>Normative values for maximal voluntary isometric contraction of the plantarflexors: A large observational cross-sectional study</b> by Samuel Briggs-Price (17735046)

    Published 2025
    Save to List
    Saved in:
  13. 53
    Table_2_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf

    Table_2_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf by Tianqi Xu (9574329)

    Published 2021
    “…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …”
    Save to List
    Saved in:
  14. 54
    Table_1_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf

    Table_1_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf by Tianqi Xu (9574329)

    Published 2021
    “…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …”
    Save to List
    Saved in:
  15. 55
    DataSheet_1_Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study.pdf

    DataSheet_1_Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study.pdf by Qian Yang (300330)

    Published 2024
    Save to List
    Saved in:
  16. 56
    Supplementary Material for: Two Novel Human Leukocyte Antigen Alleles Are Associated with Decreased Risk of Onychomycosis in a Large Cohort of Danish Blood Donors

    Supplementary Material for: Two Novel Human Leukocyte Antigen Alleles Are Associated with Decreased Risk of Onychomycosis in a Large Cohort of Danish Blood Donors by LindsøAndersen P. (14623916)

    Published 2023
    Save to List
    Saved in:
  17. 57
    Species-level changes in biomass due to large mammalian herbivore exclusion.

    Species-level changes in biomass due to large mammalian herbivore exclusion. by Arjun B. Potter (6445646)

    Published 2021
    Save to List
    Saved in:
  18. 58
    Nuclear translocation of NFATc1 is decreased in <i>Tcirg1</i>-knockdown osteoclasts.

    Nuclear translocation of NFATc1 is decreased in <i>Tcirg1</i>-knockdown osteoclasts. by Dongyan Zhang (640677)

    Published 2020
    Save to List
    Saved in:
  19. 59
    Data_Sheet_1_Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.docx

    Data_Sheet_1_Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.docx by Chengliang Yin (7545749)

    Published 2020
    “…However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear.</p>Methods<p>We investigated the influence of MMP14 on clinical prognosis using data obtained from three Gene Expression Omnibus (GEO) database sets (GSE98588, GSE10846, and GSE4475). …”
    Save to List
    Saved in:
  20. 60
    Data_Sheet_1_Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.docx

    Data_Sheet_1_Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.docx by Chengliang Yin (7545749)

    Published 2020
    “…However, the correlation between MMP14 expression, prognosis, and immune cell infiltration in diffuse large B-cell lymphoma (DLBCL) remains unclear.</p>Methods<p>We investigated the influence of MMP14 on clinical prognosis using data obtained from three Gene Expression Omnibus (GEO) database sets (GSE98588, GSE10846, and GSE4475). …”
    Save to List
    Saved in:

Search Tools: